Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Molecules Année : 2021

Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy

Cédric Lecoutey
  • Fonction : Auteur
Rémi Legay
  • Fonction : Auteur
Audrey Davis
Patrick Dallemagne

Résumé

The development of Multi-Target Directed Ligand is of clear interest for the treatment of multifactorial pathology such as Alzheimer’s disease (AD). In this context, acetylcholinesterase (AChE) inhibitors have been modulated in order to generate novel pleiotropic compounds targeting a second protein of therapeutic interest in AD. Among them, donecopride was the first example of a dual acetylcholinesterase inhibitor and 5-HT4 receptor agonist. In order to explore the structural diversity around this preclinical candidate we have explored the preparation of novel constrained analogs through late-stage rigidification strategy. A series of phenylpyrazoles was prepared in a late-stage functionalization process and all compounds were evaluated in vitro towards AChE and 5-HTRs. A docking study was performed in order to better explain the observed SAR towards AChE, 5-HT4R and 5-HT6R and this study led to the description of novel ligand targeting both AChE and 5-HT6R.

Domaines

Chimie
Fichier principal
Vignette du fichier
molecules-26-02536-v2.pdf (11.54 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03969972 , version 1 (24-01-2024)

Identifiants

Citer

Cédric Lecoutey, Rémi Legay, Audrey Davis, Jana Sopková-de Oliveira Santos, Patrick Dallemagne, et al.. Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy. Molecules, 2021, 26 (9), pp.2536. ⟨10.3390/molecules26092536⟩. ⟨hal-03969972⟩
7 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More